✦ LIBER ✦

A Phase I Dose Escalation Study of Hypofractionated IMRT Field-in-Field Boost for Newly Diagnosed Glioblastoma Multiforme

✍ Scribed by Arta M. Monjazeb; Deandra Ayala; Courtney Jensen; L. Douglas Case; J. Daniel Bourland; Thomas L. Ellis; Kevin P. McMullen; Michael D. Chan; Stephen B. Tatter; Glen J. Lesser; Edward G. Shaw

Book ID: 118455356
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 284 KB
Volume: 82
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2010.10.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I dose escalating study of inten

A phase I dose escalating study of intensity modulated radiation therapy (IMRT) for the treatment of glioblastoma multiforme (GBM)

✍ E.G Shaw; V Stieber; S Tatter; T Ellis; W Hinson; W Kearns; J.D Bourland; M Munl 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 28 KB

NTCP Modeling of Dose-escalation Hypofra

NTCP Modeling of Dose-escalation Hypofractionated Stereotactic Radiation Therapy (HFSRT) for Patients With Subtotally Resected (STR) Newly Diagnosed Glioblastoma Multiforme (GBM)

✍ Yondorf, M.; Wang, S.; Zhou, L.; Chang, J.; Desai, P.; Parashar, B.; Nori, D.; C 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Phase II study of fixed dose rate gemcit

Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme

✍ Giulio Metro; Alessandra Fabi; Maria A. Mirri; Antonello Vidiri; Andrea Pace; Ma 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 312 KB

A Phase I dose escalation trial of motex

A Phase I dose escalation trial of motexafin gadolinium (gadolinium texaphyrin, xcytrinR)as a radiation sensitizer in patients with newly diagnosed glioblastoma multiforme

✍ J.M. Ford; T. Endicott; J.R. Alger; J. Earle; D. Miles; S. Phan 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 16 KB

2509 POSTER Phase II study of fixed dose

2509 POSTER Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme (GBM): preliminary results

✍ C.M. Carapella; A. Felici; M.A. Mirri; A. Pace; M.A. Carosi; G. Metro; B. Jandol 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Phase II Trial of Hypofractionated Inten

Phase II Trial of Hypofractionated Intensity Modulated Radiotherapy to 60 Gy in 10 Fractions with Temozolomide Chemotherapy for Patients with Newly Diagnosed Glioblastoma Multiforme

✍ K. Reddy; D. Damek; L. Gaspar; D. Ney; B. Kavanagh; A. Waziri; K. Lillehei; K. S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB